Advertisement

The Lead

Dow Chemical and Cambrex Collaborate to Manufacture Drug-Solubility Solution

February 14, 2013 1:49 pm | News | Comments

Cambrex and The Dow Chemical Company have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility Enhancement. This is the final step in building on the solubilization partnership that Dow and Bend Research announced in October 2012 and it will help Dow to commercially supply solubility enabling excipients.

FDA Reviewing Decision on Safety of BPA

June 3, 2009 4:45 am | News | Comments

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — The FDA reviewing its conclusion from last...

Dow Stake Positions DNT and Starpharma as Leading Developers of Nanotechnologies for the Pharmaceutical, Biotechnology Industries

March 11, 2005 4:35 am | Product Releases | Comments

MOUNT PLEASANT, MI, (Jan. 25, 2005) - Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical

Dow Stake Positions DNT and Starpharma as Leading Developers

January 26, 2005 5:32 am | Product Releases | Comments

MOUNT PLEASANT, MI, (Jan. 25, 2005) - Dendritic NanoTechnologies Inc. (DNT), The Dow Chemical

View Sample

FREE Email Newsletter

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading